Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Erttmann

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
Bone Marrow Transplantation|November 15, 2005
Comparable results in patients with acute lymphoblastic leukemia after related and unrelated stem cell transplantationJ Dahlke, N Kröger, T Zabelina, et al.
Bone Marrow Transplantation|May 25, 1999
Use of a five-agent GVHD prevention regimen in recipients of unrelated donor marrowA R Zander, T Zabelina, N Kröger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1996
Comparison of the diagnostic and prognostic value of biological markers in neuroblastoma. Proposal for a common methodology of analysis. SENSE groupM C Favrot, P Ambros, F Schilling, et al.
Bone Marrow Transplantation|October 24, 2000
Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemiaN Kröger, T Zabelina, S Sonnenberg, et al.
Bone Marrow Transplantation|January 7, 1999
Intensified conditioning regimen in bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemiaN Kröger, W Krüger, G Wacker-Backhaus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 6, 1999
High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remissionA R Zander, C Berger, N Kröger, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1983
Adjuvant chemotherapy in osteosarcoma - effects of cisplatinum, BCD, and fibroblast interferon in sequential combination with HD-MTX and adriamycin. Preliminary results of the COSS 80 studyK Winkler, G Beron, R Kotz, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Bone Marrow Transplantation|November 15, 2005
Comparable results in patients with acute lymphoblastic leukemia after related and unrelated stem cell transplantationJ Dahlke, N Kröger, T Zabelina, et al.
Bone Marrow Transplantation|May 25, 1999
Use of a five-agent GVHD prevention regimen in recipients of unrelated donor marrowA R Zander, T Zabelina, N Kröger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1996
Comparison of the diagnostic and prognostic value of biological markers in neuroblastoma. Proposal for a common methodology of analysis. SENSE groupM C Favrot, P Ambros, F Schilling, et al.
Bone Marrow Transplantation|October 24, 2000
Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemiaN Kröger, T Zabelina, S Sonnenberg, et al.
Bone Marrow Transplantation|January 7, 1999
Intensified conditioning regimen in bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemiaN Kröger, W Krüger, G Wacker-Backhaus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 6, 1999
High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remissionA R Zander, C Berger, N Kröger, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1983
Adjuvant chemotherapy in osteosarcoma - effects of cisplatinum, BCD, and fibroblast interferon in sequential combination with HD-MTX and adriamycin. Preliminary results of the COSS 80 studyK Winkler, G Beron, R Kotz, et al.
Pageof 9